Familial TTR amyloid polyneuropathy (FAP TTR): leptomeningeal
Written and reviewed by Dr Ibrahim Imam, Consultant Neurologist. Last reviewed .
Familial TTR amyloid polyneuropathy (FAP TTR): leptomeningeal. Leptomeningeal TTR occurs in advanced stages of TTR-FAP.
Presentation
- Leptomeningeal TTR occurs in advanced stages of TTR-FAP
- It commonly presents as cerebral amyloid angiopathy (CAA)
- It may also present as ocular amyloid
Clinical features
Locked: subscribe to see this section.
Investigations
Locked: subscribe to see this section.
Investigational treatments
Locked: subscribe to see this section.
References
- Ando Y, Coelho T, Berk JL, et al. Guideline for transthyretin-related hereditary amyloidosis for clinicians. Orphanet J Rare Dis 2013; 8:31.
- Blevins G, Macaulay R, Harder S, et al. Oculoleptomeningeal amyloidosis in a large kindred with a new transthyretin variant Tyr69His. Neurology 2003; 60:1625-1630.
- Jin K, Sato S, Takahashi T, et al. Familial leptomeningeal amyloidosis with a transthyretin variant Asp18Gly representing related subarachnoid haemorrhages with superficial siderosis. JNNP 2004; 75:1463-1466.
- Pinheiro F, Varejão N, Esperante S, Santos J, et al. Tolcapone, a potent aggregation inhibitor for the treatment of familial leptomeningeal amyloidosis. FEBS J 2021; 288:310-324.
